IL2RB and TUBA1B are Potential Targets of Music Therapy for Alzheimer’s Disease and Cognitive Impairment

Announcing a new article publication for BIO Integration journal. This study examined the complex interactions among differential gene expression, immune responses, therapy-associated genes in Alzheimer’s disease (AD), and cognitive impairment, with a distinct focus on the integration of music therapy. The objective was to delineate the landscape of differentially expressed genes (DEGs), particularly the interconnections between gene expression changes and therapeutic interventions, including exercise and music therapy, to discover immune-associated therapeutic targets.

Through evaluation of the gene expression datasets GSE140831 and GSE48624, DEGs were identified and their interactions with genes whose expression is induced by exercise and music therapy were investigated. Through protein-protein interaction analysis, gene set variation analysis, immune infiltration studies, and correlation analyses, the regulatory interactions and pathway enrichments were revealed. An mRNA-miRNA interaction network was constructed to elucidate regulatory mechanisms, and a drug-target interaction analysis was performed to discover potential therapeutic avenues.

This study revealed the complex organization of DEGs. In addition to identifying IL2RB and TUBA1B, these genes were proposed as critical modulators in the context of exercise, music therapy, and AD. The results indicated a substantial upregulation of pathways, such as glycolysis and TGF-beta signaling, in response to exercise, music therapy, and AD. These pathways revealed significant changes in gene expression compared to baseline conditions, highlighting their involvement in immune response modulation. The network of mRNA-miRNA interactions revealed key regulators of immune response and cognition. The examination of drug and target interactions provided insights into potential mechanisms of action for disease modulation.

This research provides a comprehensive overview of DEGs in AD and cognitive impairment, and uniquely incorporated evaluation of music therapy. The findings underscore the importance of IL2RB and TUBA1B as potential therapeutic targets; provide initial insights into the mechanisms of immune response; and suggest new pathways for targeted treatment development.

Read More: https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-1002

BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

Please visit www.bio-integration.org to learn more about the journal.

Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the ScienceOpen platform (https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).

Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/bioi).

There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).

ISSN 2712-0074

eISSN 2712-0082

Ke Wu, Jianling Liu and Yusheng Su et al. IL2RB and TUBA1B are Potential Targets of Music Therapy for Alzheimer’s Disease and Cognitive Impairment. BIOI. 2025. Vol. 6(1). DOI: 10.15212/bioi-2025-1002